ZIM Laboratories informs about press release
ZIM Laboratories has informed that it enclosed the Press Release relating to grant of Marketing Authorization for ‘Rizatriptan Benzoate Orally Disintegrating Strips’ in Australia by the Therapeutic Goods Administration (TGA), to ZIMTAS PTY LTD. (‘ZIMTAS’), Subsidiary of the company.
The above information is a part of company’s filings submitted to BSE.
